Related articles

Immunotherapy

Therapeutic approach reinforced by tarlatamab plus durvalumab and other agents in aggressive cancers.

• Oncologists in Chicago and Madrid Erupt in Standing Ovations for Breakthroughs Against Pancreatic and Lung Cancer